Provided by Tiger Fintech (Singapore) Pte. Ltd.

Werewolf Therapeutics, Inc.

1.46
+0.04503.19%
Volume:248.56K
Turnover:361.86K
Market Cap:65.29M
PE:-0.87
High:1.49
Open:1.45
Low:1.40
Close:1.41
Loading ...

Werewolf Therapeutics to Participate in the KidneyCAN 7th Annual Kidney Cancer Research Summit

GlobeNewswire
·
09 Jul

Werewolf Therapeutics Inc. Conducted Annual Stockholders Meeting

Reuters
·
14 Jun

Werewolf Therapeutics to Participate in Jefferies Global Healthcare Conference

Reuters
·
29 May

Werewolf Therapeutics price target lowered to $9 from $10 at BofA

TIPRANKS
·
27 May

RA Capital Management, L.P. Reports Acquisition of Common Shares of Werewolf Therapeutics Inc

Reuters
·
15 May

Werewolf Therapeutics Inc Files for Mixed Shelf of up to $150 Mln - SEC Filing

THOMSON REUTERS
·
09 May

Werewolf Therapeutics, Inc. : H.c. Wainwright Cuts Target Price to $10 From $15

THOMSON REUTERS
·
08 May

Werewolf Therapeutics Inc: Updated Cash Guidance Provides Runway Into Q4 of 2026

THOMSON REUTERS
·
08 May

Werewolf Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire
·
05 May

Press Release: Werewolf Therapeutics Appoints Steven Bloom as Chief Business Officer

Dow Jones
·
17 Apr

Werewolf Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference

GlobeNewswire
·
31 Mar

Promising Investment in Werewolf Therapeutics: Strong Financials and Strategic Partnerships Drive Growth Prospects

TIPRANKS
·
13 Mar

Analysts Are Bullish on Top Healthcare Stocks: Werewolf Therapeutics (HOWL), Exelixis (EXEL)

TIPRANKS
·
13 Mar

Werewolf Therapeutics Faces Geopolitical Risks Amid Changing Trade Policies with China

TIPRANKS
·
12 Mar

Werewolf Therapeutics Q4 2024 GAAP EPS $(0.46) Misses $(0.42) Estimate, As Of December 31, 2024, Cash And Cash Equivalents Were $111M, Expected To Provide Cash Runway Into Q2 Of 2026

Benzinga
·
11 Mar

Werewolf Therapeutics to Present at the 2025 Leerink Partners Global Biopharma Conference

GlobeNewswire
·
04 Mar

Pacira (PCRX) Tops Q4 Earnings Estimates

Zacks
·
28 Feb

Werewolf Therapeutics Appoints Anil Singhal to Board

TIPRANKS
·
24 Feb

Werewolf Therapeutics appoints Anil Singhal to board of directors

TIPRANKS
·
24 Feb

Werewolf Therapeutics Appoints Anil Singhal, Ph.d., to Its Board of Directors

THOMSON REUTERS
·
24 Feb